Baseline characteristics, including pN stage, diagnosis year, histologic grade, tumor location, laterality, tumor size, ER/PR status, and human epidermal growth factor receptor 2 (HER‐2) expression, were well‐balanced between the two groups, as presented in Table 1 (left column). This evidence concerns the gene ERBB2 and neoplasm.